Mapping the Potential of Microfluidics in Early Diagnosis and Personalized Treatment of Head and Neck Cancers

5Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Head and neck cancers (HNCs) account for ~4% of all cancers in North America and encompass cancers affecting the oral cavity, pharynx, larynx, sinuses, nasal cavity, and salivary glands. The anatomical complexity of the head and neck region, characterized by highly perfused and innervated structures, presents challenges in the early diagnosis and treatment of these cancers. The utilization of sub-microliter volumes and the unique phenomenon associated with microscale fluid dynamics have facilitated the development of microfluidic platforms for studying complex biological systems. The advent of on-chip microfluidics has significantly impacted the diagnosis and treatment strategies of HNC. Sensor-based microfluidics and point-of-care devices have improved the detection and monitoring of cancer biomarkers using biological specimens like saliva, urine, blood, and serum. Additionally, tumor-on-a-chip platforms have allowed the creation of patient-specific cancer models on a chip, enabling the development of personalized treatments through high-throughput screening of drugs. In this review, we first focus on how microfluidics enable the development of an enhanced, functional drug screening process for targeted treatment in HNCs. We then discuss current advances in microfluidic platforms for biomarker sensing and early detection, followed by on-chip modeling of HNC to evaluate treatment response. Finally, we address the practical challenges that hinder the clinical translation of these microfluidic advances.

References Powered by Scopus

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

75366Citations
N/AReaders
Get full text

The origins and the future of microfluidics

7898Citations
N/AReaders
Get full text

Nivolumab for recurrent squamous-cell carcinoma of the head and neck

3902Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Microfluidic-based nanoplatforms for cancer theranostic applications: A mini-review on recent advancements

5Citations
N/AReaders
Get full text

In Vitro Models of Head and Neck Cancer: From Primitive to Most Advanced

5Citations
N/AReaders
Get full text

Synergistic potential of stem cells and microfluidics in regenerative medicine

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Pillai, S., Kwan, J. C., Yaziji, F., Yu, H., & Tran, S. D. (2023, August 1). Mapping the Potential of Microfluidics in Early Diagnosis and Personalized Treatment of Head and Neck Cancers. Cancers. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/cancers15153894

Readers over time

‘23‘24‘2505101520

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

75%

Professor / Associate Prof. 1

25%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 2

29%

Pharmacology, Toxicology and Pharmaceut... 2

29%

Chemical Engineering 2

29%

Medicine and Dentistry 1

14%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0